Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma

Oscar Calzada, Jeffrey M. Switchenko, Joseph J. Maly, Kristie A. Blum, Natalie Grover, Stephanie Mathews, Steven I. Park, Max Gordon, Alexey Danilov, Narendranath Epperla, Timothy S. Fenske, Mehdi Hamadani, Christopher R. Flowers, Jonathon B. Cohen

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences